Matches in Nanopublications for { ?s ?p "[Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- assertion description "[Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP599262.RAczqYuhx359xSvN8FBqNKDz7h0n3WwLfgg5wsUeB7-Ws130_assertion description "[Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599262.RAczqYuhx359xSvN8FBqNKDz7h0n3WwLfgg5wsUeB7-Ws130_provenance.
- NP599274.RAZ0nU3SuzLcNo4c-z3BIjF9gaIOEVblt6e_z1Q5jZcBw130_assertion description "[Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599274.RAZ0nU3SuzLcNo4c-z3BIjF9gaIOEVblt6e_z1Q5jZcBw130_provenance.
- NP599263.RApNiJuhWIXBmn17MGpuLH2W_iZNzeeHNmtLqEY_sF-Ig130_assertion description "[Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599263.RApNiJuhWIXBmn17MGpuLH2W_iZNzeeHNmtLqEY_sF-Ig130_provenance.
- NP599265.RAICQXFEozOq3m9CTiWZTiQMYpW7OENV59W4wmDt0VuR8130_assertion description "[Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599265.RAICQXFEozOq3m9CTiWZTiQMYpW7OENV59W4wmDt0VuR8130_provenance.
- NP599269.RALEaBOeeyqRMN1xuxitjRNjb_WVOUlOwwa4eny7ZyDUs130_assertion description "[Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599269.RALEaBOeeyqRMN1xuxitjRNjb_WVOUlOwwa4eny7ZyDUs130_provenance.
- NP599261.RA49UxE85aZjtDUWFw2Xhf-U_avwv6GG3oqLU8ydHOo_U130_assertion description "[Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599261.RA49UxE85aZjtDUWFw2Xhf-U_avwv6GG3oqLU8ydHOo_U130_provenance.
- NP599273.RA_DRQN1Uv_uYY92i3lFSqmXQbJEocFms6Rs14gxckS9Y130_assertion description "[Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599273.RA_DRQN1Uv_uYY92i3lFSqmXQbJEocFms6Rs14gxckS9Y130_provenance.